SCHEMBL4072849

SCHEMBL4072849

NC(=O)[C@@H](C[C@H](O)[C@@H](N)Cc1ccccc1)C1CCOCC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 8/20 0.57
TACR2 P21452 1/20 0.41
SLC15A1 P46059 1/20 0.39
MME P08473 1/20 0.39
CSNK1E P49674 1/20 0.39
EPHX1 P07099 1/20 0.38
ALPI P09923 1/20 0.37
PKM P14618 1/20 0.37
PTGS1 P23219 1/20 0.37
XIAP P98170 1/20 0.37
SLC7A5 Q01650 1/20 0.37
DPP4 P27487 1/20 0.37
SLC1A3 P43003 1/20 0.36
SLC1A2 P43004 1/20 0.36
SLC1A1 P43005 1/20 0.36
REN P00797 2/20 0.35
LAP3 P28838 2/20 0.35
ANPEP P15144 1/20 0.35
RNPEP Q9H4A4 1/20 0.35
DNPEP Q9ULA0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4068618 0.89 CCR1 (0.55) CCR1SLC15A1CSNK1EEPHX1ALPI
SCHEMBL6687785 0.88 CCR1 (0.56) CCR1SLC15A1CSNK1EEPHX1ANPEP
SCHEMBL7586283 0.88 CCR1 (0.56) CCR1SLC15A1CSNK1EEPHX1ANPEP
SCHEMBL4067461 0.88 CCR1 (0.56) CCR1SLC15A1CSNK1EEPHX1ANPEP
SCHEMBL27586171 0.88 CCR1 (0.56) CCR1SLC15A1CSNK1EEPHX1ANPEP
SCHEMBL2675154 0.88 CCR1 (0.56) CCR1SLC15A1CSNK1EEPHX1ANPEP
SCHEMBL4061506 0.85 LMNA (0.46) CCR1SLC15A1CSNK1EEPHX1REN
SCHEMBL4065521 0.83 CCR1 (0.58) CCR1SLC15A1CSNK1EEPHX1ALPI
SCHEMBL4066052 0.82 CCR1 (0.42) CCR1SLC15A1CSNK1EEPHX1ALPI
SCHEMBL4068034 0.81 CCR1 (0.58) CCR1SLC15A1CSNK1EEPHX1ALPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0966443-B1 HETEROARYL-HEXANOIC ACID AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS SELECTIVE INHIBITORS OF MIP-1-ALPHA BINDING TO ITS CCR1 RECEPTOR PFIZER (US) 2009-01-28 EP disclosed